Chemotherapy-induced cardiomyopathy

Heart Failure Reviews
Angela Y HigginsJames D Chang

Abstract

Cardiomyopathy is an adverse outcome of antineoplastic drug therapy that has become increasingly relevant in the management of cancer survivors. As the efficacy of anticancer treatments has improved, long-term outcomes are altered by the development of cardiotoxicity, which may be associated with an even worse prognosis than that of the underlying malignancy. From the research into mechanisms, prevention, and treatment, the specialized field of cardio-oncology has evolved, but the recognition and appropriate management of these patients is important for the general internist and general cardiologist as well. Although antineoplastic chemotherapy can cause multiple forms of cardiotoxicity, including arrhythmia, pericardial disease, valvular dysfunction, and myocardial ischemia, in this review we will focus on chemotherapeutic agents associated with cardiomyopathies, from the anthracyclines to newer, the so-called targeted agents such as tyrosine kinase inhibitors. We also review the diagnostic modalities for chemotherapy-induced cardiomyopathy as well as the prevention and treatment strategies which may prolong the lives of those suffering from cancer.

References

Nov 1, 1979·Annals of Internal Medicine·D D Von HoffF M Muggia
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·K KandylisA P Efremidis
May 1, 1981·Archives of Internal Medicine·J S GottdienerJ Ziegler
Nov 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P AnderliniS A Pierce
Jan 1, 1994·Ultrastructural Pathology·B MackayR S Benjamin
Jan 1, 1993·Annals of Internal Medicine·Z M QuezadoF P Ognibene
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M SwainR A Gams
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M SwainR A Gams
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M LopezC L Maini
Aug 17, 1999·Cancer Treatment Reviews·M T MeinardiD T Sleijfer
Aug 10, 2000·Journal of the American College of Cardiology·D CardinaleC Fiorentini
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SeidmanDeborah Keefe
Apr 4, 2003·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Isao MitaniBarry L Zaret
Sep 27, 2003·Circulation Research·Steven P JonesEduardo Marbán
Mar 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E R O'BrienUNKNOWN CAELYX Breast Cancer Study Group
Aug 25, 2004·The Breast : Official Journal of the European Society of Mastology·Amy TierstenAndrea Troxel
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S Ewer, Scott M Lippman
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S EwerDaniel J Lenihan
Jan 21, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MartyUNKNOWN Dexrazoxane Study Group
Jul 4, 2006·European Journal of Pharmacology·Yenjerla MythiliPalaninathan Varalakshmi
Jul 25, 2006·Nature Medicine·Risto KerkeläThomas Force
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valentina GuarneriFrancisco J Esteva
Dec 13, 2006·Journal of the American College of Cardiology·Nihat KalayAli Ergin
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jul 6, 2007·The New England Journal of Medicine·Clifford A Hudis
Jul 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M SuterMartine J Piccart-Gebhart
Dec 18, 2007·Lancet·Tammy F ChuMing Hui Chen
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezRichard J Rodeheffer
Apr 26, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L TelliS Srinivas
Jun 6, 2008·Mayo Clinic Proceedings·Edith A PerezMichael S Ewer
Oct 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manuela SchmidingerHerwig Schmidinger
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martee L HensleyLynn M Schuchter
Dec 4, 2009·Chemical Research in Toxicology·Pierantonio MennaGiorgio Minotti
Feb 2, 2010·Journal of the American College of Cardiology·Daniela CardinaleCarlo M Cipolla

❮ Previous
Next ❯

Citations

May 28, 2016·Heart Failure Reviews·Donato MeleGiuseppe Mercuro
Feb 18, 2016·American Journal of Therapeutics·Mary E RothCarrie B Lee
Feb 13, 2018·Frontiers in Pharmacology·Shuxu DuTianyou Wang
Aug 25, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Kelsie E OatmenFrancis G Spinale
Apr 12, 2019·Circulation Research·Ion CristóbalJesús García-Foncillas
Feb 19, 2020·Journal of Cellular and Molecular Medicine·Hai-Ru LiJia-Wei Tian
Mar 30, 2019·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Katie K WolfeLauren E Marsillio
Nov 27, 2020·Frontiers in Chemistry·Cerise M SiamofWeibo Cai
Dec 16, 2020·International Journal of Cardiology·Nooraldaem YousifSlayman Obeid
Sep 1, 2020·Magnetic Resonance Imaging·El-Sayed H IbrahimCarmen Bergom
Apr 4, 2021·Diagnostics·Alejandro Meraz-MunozPrakash Gudsoorkar
May 3, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yanping ZhangDan Shi
Jul 3, 2021·Cancers·Tamara Mc ErlainCristina M Branco
Jun 18, 2021·Toxicology Reports·Miyuki KobaraTetsuo Nakata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
Rui AdãoCarmen Brás-Silva
Current Cardiology Reports
Sachin Shah, Anju Nohria
© 2021 Meta ULC. All rights reserved